Raltegravir — Drug Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

0 Recruiting

2 Completed trials

3 Sponsors

8 Countries

Phase III

Phase I/II

Phase IV

Phase III: 1 Phase I/II: 1 Phase IV: 1

Sponsors using this IMP

3 total

DORAL Pending

2024-513941-35-00 Phase I/II 3 countries Centre de Recherches et d’Etudes sur les Pathologies Infectieuses, Tropicales et…
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 ( ISLEND-… Ended

2024-514047-28-00 Phase III 4 countries Gilead Sciences Inc.
Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Ended

2024-515487-31-00 Phase IV 5 countries Stichting Radboud universitair medisch centrum

Showing 1–3 of 3 trials